Abstract
Optimal BP targets for individuals with hypertension and CKD continue to be debated. The evidence base is heavily influenced by three trials: the Modification of Diet in Renal Disease (MDRD) study, the African American Study of Kidney Disease and Hypertension (AASK), and, more recently, the Systolic
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have